train
(N=92)
validation
(N=102)
TRUE
(N=194)
P-value
Age(years)
Mean (SD) 63.3 (7.91) 64.1 (8.33) 63.7 (8.12) 1
Median [Min, Max] 64.5 [35.0, 76.0] 66.0 [33.0, 80.0] 65.0 [33.0, 80.0]
Sex
FeMale 10 (10.9%) 11 (10.8%) 21 (10.8%) 1
Male 82 (89.1%) 91 (89.2%) 173 (89.2%)
Smoking
No 16 (17.4%) 32 (31.4%) 48 (24.7%) 0.0789
Yes 76 (82.6%) 70 (68.6%) 146 (75.3%)
Pathologic subtype
Non squamous 48 (52.2%) 58 (56.9%) 106 (54.6%) 0.807
Squamous 44 (47.8%) 44 (43.1%) 88 (45.4%)
PFS(months)
Mean (SD) 15.3 (10.6) 13.4 (6.44) 14.3 (8.68) 1
Median [Min, Max] 12.5 [0.600, 37.4] 13.1 [0.367, 27.9] 12.7 [0.367, 37.4]
OS(months)
Mean (SD) 20.7 (10.7) 14.5 (6.47) 17.4 (9.26) 1
Median [Min, Max] 20.9 [1.33, 39.3] 14.8 [0.367, 27.9] 16.5 [0.367, 39.3]
PD-L1 TPS group
<1% 11 (12.0%) 9 (8.8%) 20 (10.3%) 0.93
1-50% 19 (20.7%) 16 (15.7%) 35 (18.0%)
>=50% 12 (13.0%) 18 (17.6%) 30 (15.5%)
Missing 50 (54.3%) 59 (57.8%) 109 (56.2%)
Clinical benefit
DCB 69 (75.0%) 89 (87.3%) 158 (81.4%) 0.165
NDB 23 (25.0%) 12 (11.8%) 35 (18.0%)
Unknown 0 (0%) 1 (1.0%) 1 (0.5%)
LDH
Mean (SD) 241 (160) 242 (189) 241 (175) 1
Median [Min, Max] 189 [66.7, 1110] 193 [96.0, 1660] 190 [66.7, 1660]
Missing 1 (1.1%) 5 (4.9%) 6 (3.1%)
NLR
Mean (SD) 3.84 (2.05) 4.05 (2.74) 3.95 (2.43) 1
Median [Min, Max] 3.37 [1.04, 9.80] 3.30 [1.15, 16.3] 3.32 [1.04, 16.3]
Missing 0 (0%) 2 (2.0%) 2 (1.0%)
Bone metastasis
No 59 (64.1%) 51 (50.0%) 110 (56.7%) 0.14
Yes 33 (35.9%) 51 (50.0%) 84 (43.3%)
Brain metastasis
No 76 (82.6%) 86 (84.3%) 162 (83.5%) 0.95
Yes 16 (17.4%) 16 (15.7%) 32 (16.5%)
Liver metastasis
No 84 (91.3%) 83 (81.4%) 167 (86.1%) 0.137
Yes 8 (8.7%) 19 (18.6%) 27 (13.9%)
Pleura metastasis
No 69 (75.0%) 71 (69.6%) 140 (72.2%) 0.705
Yes 23 (25.0%) 31 (30.4%) 54 (27.8%)
Lymph metastasis
No 46 (50.0%) 36 (35.3%) 82 (42.3%) 0.117
Yes 46 (50.0%) 66 (64.7%) 112 (57.7%)